欢迎您, 登录 | 注册

首页 | English

X
加载中

Eosinophils are multifunctional effector cells implicated in the pathogenesis of a variety of diseases including asthma, eosinophil gastrointestinal disorders and helminth infection. Mouse bone marrow derived progenitor cells can be differentiated into eosinophils following IL-5 exposure. These bone marrow derived eosinophils are fully differentiated at the end of a 14 day culture based on morphology and expression of molecular markers.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Bone Marrow Derived Eosinophil Cultures
骨髓源嗜酸性细胞培养

免疫学 > 免疫细胞分离 > 维持和分化
作者: Thomas X. Lu
Thomas X. LuAffiliation: Division of Pediatrics, Cincinnati Children's Hospital Medical Center / University of Cincinnati, Cincinnati, USA
Bio-protocol author page: a1440
 and Marc E. Rothenberg
Marc E. RothenbergAffiliation: Division of Pediatrics, Cincinnati Children's Hospital Medical Center / University of Cincinnati, Cincinnati, USA
For correspondence: marc.rothenberg@cchmc.org
Bio-protocol author page: a1441
Vol 4, Iss 12, 6/20/2014, 2794 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1161

[Abstract] Eosinophils are multifunctional effector cells implicated in the pathogenesis of a variety of diseases including asthma, eosinophil gastrointestinal disorders and helminth infection. Mouse bone marrow derived progenitor cells can be differentiated into eosinophils following IL-5 exposure. These bone marrow derived eosinophils are fully differentiated at the end of a 14 day culture based on morphology and expression of molecular markers.

Materials and Reagents

  1. Mice
  2. Histopaque 1083 (Sigma-Aldrich, catalog number: 10831-100ml)
  3. IMDM with Glutamax-I (Life Technologies, InvitrogenTM, catalog number: 31980-097)
  4. Fetal Bovine Serum (FBS) (Atlanta Biologicals, catalog number: S11150)
  5. Penicillin/Streptomycin (Life Technologies, InvitrogenTM, catalog number: 15140-122)
  6. Stem Cell Factor (Pepro tech, catalog number: 250-03)
  7. FLT-3 Ligand (Pepro tech, catalog number: 250-31L)
  8. Recombinant mouse IL-5 (Pepro tech, catalog number: 215-15)
  9. PBS (Life Technologies, InvitrogenTM, catalog number: 14200-166)
  10. Diff-Quick Stain Kit (Thermo Fisher Scientific, catalog numbers: 23-122-929, 23-122-952, and 23-122-937)
  11. RBC lysis buffer (Sigma-Aldrich, catalog number: R7757-100ml)
  12. CCR3 (R&D systems, Catalog number: FAB729F)
  13. Siglec-F (BD, PharmingenTM, Catalog number: 552126)
  14. IMDM cell culture media (see Recipes)

Equipment

  1. 6-well tissue culture plate
  2. Dissection tools: scalpel, scissors
  3. 1 ml syringe
  4. 15 ml sterile centrifuge tube
  5. Centrifuge
  6. 37 °C, 5% CO2 cell culture incubator
  7. Microscope
  8. Hemocytometer

Procedure

  1. Collect femur/tibia from 6-8 mice.
    Note: Mice between 6-8 weeks old will give the highest yield of low-density bone marrow fraction.
  2. Flush the bone marrow from femur/tibia with PBS, pipet up and down to break up the bone marrow into single cell suspension.
  3. Spin down the cells at 300 x g 8 min at 4 °C.
  4. Resuspend cells in 15 ml of RBC lysis buffer, incubate for 2 min at 37 °C.
    Note: If less than 6-8 mice were used, there is no need to adjust the volume of RBC lysis buffer. If more than 6-8 mice were used, we recommend scaling up the RBC lysis buffer accordingly and also scaling up the amount of PBS used to neutralize the RBC lysis buffer in step 5.
  5. Add 30 ml of PBS to neutralize the RBC lysis buffer.
  6. Spin down the cells at 300 x g 8 min at 4 °C.
  7. Resuspend the cells in 16 ml of PBS.
  8. Add 4 ml of histopaque 1083 to each of 15 ml centrifuge tube.
  9. Carefully layer 4 ml of cells from step 7 to 4 ml of histopage 1083 prepared in step 8. Must use very slow speed to ensure that the layers are not disturbed. At the end of this step, there should be two layers: bottom clear layer contains histopage 1083, and top cloudy layer contaning cells.
  10. Centrifuge at 400 x g for exactly 30 min at room temperature. The brake on the centrifuge needs to be in the off position.
  11. Collect the low density fraction with a 1 ml micropipette. The low density fraction is at the interface between upper and lower layers. The approximate volume of this fraction is 0.5 ml to 1 ml.
    Note: The low-density fraction is cloudy due to the low-density bone marrow cells at this fraction. The upper layer immediately above it is clear. The lower layer immediately below it should be significantly less cloudy compared to the low-density fraction.
  12. Wash the cells with 30 ml of PBS and spin down at 300 x g 8 min.
  13. Resusped the cells in IMDM with Glutamax-1 with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin supplemented with 100 ng/ml stem cell factor and 100 ng/ml FLT-3 ligand at a concentration of 1 x 106/ml.
  14. Plate 3 x 106 cells per well in 6 well plates (3 ml).
  15. Change culture media on day 2 by aspirating 1.5 ml of media from each well and adding 1.5 ml of new media (see Recipes).
    Note: Be careful not to aspirate the cells as the cells are settled to the bottom of the plate but are not attached.
  16. On day 4 , collect all the cells, spin down the cells at 300 x g 8 min at 4 °C, wash once with 30 ml of PBS, then resuspend the cells at a concentration of 1 x 106/ml in IMDM with Glutamax-1 with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin supplemented with 10 ng/ml of IL-5.
  17. Change the culture culture media every other day. Cells should be counted and concentration adjusted to 1 x 106/ml during each media change.
  18. At day 14, collect mature eosinophils for further studies. Eosinophil maturity can be assessed by FACS staining for CCR3 and Siglec-F and/or Diff-Quik staining of cytospin preparations following the manufacturer’s protocol (Figure 1).


    Figure 1. Morphology of mature bone marrow derived eosinophils. Morphology determined by Diff-Quik staining following the manufacturer’s protocol.

Recipes

  1. IMDM cell culture media
    IMDM with Glutamax-1
    10% FBS
    100 U/ml penicillin
    100 μg/ml streptomycin supplemented with 100 ng/ml stem cell factor
    100 ng/ml FLT-3 ligand
    Cellular concentration of 1 x 106/ml

Acknowledgments

This protocol has been adapted from Lu et al. (2013).

References

  1. Lu, T. X., Lim, E. J., Besse, J. A., Itskovich, S., Plassard, A. J., Fulkerson, P. C., Aronow, B. J. and Rothenberg, M. E. (2013). MiR-223 deficiency increases eosinophil progenitor proliferation. J Immunol 190(4):1576-1582.


How to cite this protocol: Lu, T. X. and Rothenberg, M. E. (2014). Bone Marrow Derived Eosinophil Cultures. Bio-protocol 4(12): e1161. DOI: 10.21769/BioProtoc.1161; Full Text



可重复性反馈:

  • 添加图片
  • 添加视频

我们的目标是让重复别人的实验变得更轻松,如果您已经使用过本实验方案,欢迎您做出评价。我们鼓励上传实验图片或视频与小伙伴们(同行)分享您的实验心得和经验。(评论前请登录)

问题&解答:

  • 添加图片
  • 添加视频

(提问前,请先登陆)bio-protocol作为媒介平台,会将您的问题转发给作者,并将作者的回复发送至您的邮箱(在bio-protocol注册时所用的邮箱)。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片或者视频的形式来说明遇到的问题。由于本平台用Youtube储存、播放视频,作者需要google 账户来上传视频。


登陆 | 注册
分享
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook